Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
103 studies found for:    "Kidney Diseases, Cystic"
Show Display Options
Rank Status Study
21 Recruiting Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)
Condition: Polycystic Kidney Disease
Interventions: Dietary Supplement: Niacinamide;   Other: Placebo
22 Recruiting Effect of the Aquaretic Tolvaptan on Nitric Oxide System
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Tolvaptan;   Drug: Placebo
23 Recruiting The German ADPKD Tolvaptan Treatment Registry
Condition: ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Intervention:
24 Recruiting Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults With ADPKD
Condition: Polycystic Kidney, Autosomal Dominant
Interventions: Drug: Curcumin;   Other: Placebo
25 Active, not recruiting Clinical Implications of DNA Analysis on ADPKD
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
26 Active, not recruiting Diagnostic Relevance of Laser Confocal Microscopy for the Screening of Upper Urinary Tract Tumors
Conditions: Hematuria,;   Nephrolithiasis;   Cancer of Urinary Tract;   Ureteropelvic Junction Obstruction
Intervention: Device: Laser confocal microscopy
27 Enrolling by invitation Open-label Trial to Evaluate the Long Term Safety of Titrated Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Drug: Tolvaptan (OPC-41061)
28 Completed New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease
Conditions: Autosomal Dominant Polycystic Kidney Disease;   Kidney Disease
Intervention:
29 Completed Diet as a Potential Treatment for Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Intervention: Behavioral: Diet and water adjustment
30 Recruiting The Eurocyst Initiative: Building a Network of ADPKD Reference Centers Across Europe
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
31 Completed Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney Disease
Conditions: Chronic Renal Failure;   Polycystic Kidney Disease
Intervention: Biological: Intravenous injection autologous mesenchymal stem cells
32 Recruiting Clinical Care of Autosomal Polycystic Kidney Disease: Retrospective Analysis and Prospective PKD Genotyping
Condition: ADPKD
Intervention:
33 Active, not recruiting Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease
Conditions: Chronic Kidney Disease;   Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Tolvaptan (OPC-41061);   Drug: Placebo
34 Completed Evaluation of Gut Bacteria in Patients With Polycystic Kidney Disease
Condition: Polycystic Kidney Disease
Intervention:
35 Recruiting Randomized Trial of NSAID vs Placebo Prior to Ureteral Stent Removal
Conditions: Disorder of Urinary Stent;   Ureteral Spasm;   Ureteropelvic Junction Obstruction;   Urolithiasis
Interventions: Drug: Ibuprofen;   Drug: Placebo
36 Active, not recruiting Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease
Condition: Polycystic Kidney Disease
Intervention: Dietary Supplement: Niacinamide
37 Completed Dismembered Pyeloplasty With and Without After Coming Stent
Conditions: Pelviureteric Junction Obstruction;   Pyeloplasty;   Neonatal Hydronephrosis;   Obstructive Uropathy;   Urinary Stent
Interventions: Procedure: After coming stent after dismembered pyeloplasty;   Procedure: Stentless dismembered pyeloplasty
38 Recruiting The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Everolimus;   Drug: Calcineurin inhibitors maintenance
39 Recruiting Lanreotide In Polycystic Kidney Disease Study
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD
Interventions: Drug: Lanreotide;   Drug: saline
40 Completed Effects of Somatostatin on Liver in ADPKD
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: octeotride;   Drug: placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years